期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Comparative efficacy and safety between endoscopic submucosal dissection,surgery and definitive chemoradiotherapy in patients with cT1N0M0 esophageal cancer
1
作者 Shu-Ai Luo Yu-Ying Sun +1 位作者 Ya-Ting Zeng Chun-Yu Huang 《World Journal of Gastrointestinal Endoscopy》 2024年第2期72-82,共11页
BACKGROUND Endoscopic submucosal dissection(ESD)and surgical resection are the standard of care for cT1N0M0 esophageal cancer(EC),whereas definitive chemoradiotherapy(d-CRT)is a treatment option.Nevertheless,the compa... BACKGROUND Endoscopic submucosal dissection(ESD)and surgical resection are the standard of care for cT1N0M0 esophageal cancer(EC),whereas definitive chemoradiotherapy(d-CRT)is a treatment option.Nevertheless,the comparative efficiency and safety of ESD,surgery and d-CRT for cT1N0M0 EC remain unclear.AIM To compare the efficiency and safety of ESD,surgery and d-CRT for cT1N0M0 EC.METHODS We retrospectively analyzed the hospitalized data of a total of 472 consecutive patients with cT1N0M0 EC treated at Sun Yat-sen University Cancer center between 2017-2019 and followed up until October 30th,2022.We analyzed demographic,medical recorded,histopathologic characteristics,imaging and endoscopic,and follow-up data.The Kaplan-Meier method and Cox proportional hazards modeling were used to analyze the difference of survival outcome by treatments.Inverse probability of treatment weighting(IPTW)was used to minimize potential confounding factors.RESULTS We retrospectively analyzed patients who underwent ESD(n=99)or surgery(n=220)or d-CRT(n=16)at the Sun Yat-sen University Cancer Center from 2017 to 2019.The median follow-up time for the ESD group,the surgery group,and the d-CRT group was 42.0 mo(95%CI:35.0-60.2),45.0 mo(95%CI:34.0-61.75)and 32.5 mo(95%CI:28.3-40.0),respectively.After adjusting for background factors using IPTW,the highest 3-year overall survival(OS)rate and 3-year recurrence-free survival(RFS)rate were observed in the ESD group(3-year OS:99.7% and 94.7% and 79.1%;and 3-year RFS:98.3%,87.4% and 79.1%,in the ESD,surgical,and d-CRT groups,respectively).There was no difference of severe complications occurring between the three groups(P≥0.05).Multivariate analysis showed that treatment method,histology and depth of infiltration were independently associated with OS and RFS.CONCLUSION For cT1N0M0 EC,ESD had better long-term survival and lower hospitalization costs than those who underwent d-CRT and surgery,with a similar rate of severe complications occurring. 展开更多
关键词 Retrospective study ct1n0m0 Esophageal squamous cell carcinoma Endoscopic submucosal dissection SURGERY Definitive chemoradiotherapy
下载PDF
cT1N0M0期食管癌内镜下非治愈性切除的研究进展
2
作者 吴振坤(综述) 王贵齐(审校) 《中国肿瘤临床》 CAS 2024年第5期253-257,共5页
随着消化内镜诊疗活动的广泛开展,内镜下切除已成为cT1N0M0期食管癌的标准治疗方案之一。然而,术后病理确认的非治愈性切除患者仍然面临复杂的后续管理选择。本文就cT1N0M0期食管癌内镜下非治愈性切除的国内外研究进展进行综述,指出现... 随着消化内镜诊疗活动的广泛开展,内镜下切除已成为cT1N0M0期食管癌的标准治疗方案之一。然而,术后病理确认的非治愈性切除患者仍然面临复杂的后续管理选择。本文就cT1N0M0期食管癌内镜下非治愈性切除的国内外研究进展进行综述,指出现有指南有关非治愈性切除的定义尚存争议,同时针对这部分患者,应在临床实践中制定选择性的个体化管理策略。 展开更多
关键词 内镜下切除 内镜黏膜下剥离术 非治愈性切除 ct1n0m0 食管鳞癌
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部